Filing Details

Accession Number:
0001209191-23-060009
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-29 16:35:37
Reporting Period:
2023-12-28
Accepted Time:
2023-12-29 16:35:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1160308 Savara Inc SVRA Pharmaceutical Preparations (2834) 841318182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1573429 Matthew Pauls One Summit Square,
1717 Langhorne Newtown Road, Suite 300
Langhorne PA 19047
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-28 84,000 $4.71 1,302,674 No 4 S Direct
Common Stock Disposition 2023-12-28 19,000 $0.00 1,283,674 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 G Direct
Footnotes
  1. Represents shares sold to satisfy tax liability upon the vesting of restricted stock units.
  2. The price is a weighted average sales price. The sale prices ranged from $4.70 to $4.795. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  3. The reporting person made a bona fide gift to The Pennington School.